Clinical Trials


lab

Current Trials

Foralumab Investigational Nasal Spray

The aim of this study is to potentially prevent the immune system attack and to dampen inflammation in the brain. We want to see if Foralumab can help people with non-active secondary progressive multiple sclerosis (na-SPMS) and if Foralumab is safe to take without causing too many side effects. We also want to see how Foralumab affects the body’s immune system and impacts clinical and imaging measures of MS.

Weill Cornell Medicine Multiple Sclerosis Center 1305 York Ave., Second Floor New York, NY 10021